Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 01/15 03:59:59 pm
74.14 EUR   +1.70%
2018SANOFI : Shares Jump After Healthy 3Q -- Update
DJ
2018Vaccines and Genzyme help Sanofi keep promise of return to growth
RE
2018SANOFI SA : quaterly earnings release
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sanofi : $82.99 Million Federal Contract Awarded to Sanofi Pasteur

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 02:41am EST

ATLANTA, Georgia, Jan. 11 -- Sanofi Pasteur Inc., Swiftwater, Pennsylvania, won an $82,991,898 federal contract from the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention for adult influenza vaccines.

Agency contacts: Monica D. Shaw, 770/488-8213, monica.shaw@cdc.hhs.gov; or Pellumbeshe Hoxhaj, 770/488-2805, kfx2@cdc.gov. CIV5FCA5. CLASS65; NAICS325412.

For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897.

© 2019 Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
02:44pEuropean nations weigh impact of Brexit on drug supplies
RE
02:09pDrug companies greet 2019 with U.S. price hikes
RE
01/14SANOFI : FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccinat..
PR
01/11SANOFI : Availability of the Pre-quarterly Results Communication
GL
01/11SANOFI : Regeneron and Sanofi restructure immuno-oncology collaboration
AQ
01/09REGENERON PHARMACEUTICALS : Sanofi Restructure Immuno-Oncology Collaboration
AQ
01/09DENALI THERAPEUTICS : Announces First Patient Dosed in Phase 1b Study of DNL747 ..
AQ
01/08EUROPE MARKETS: European Markets Jump As Hopes Over Trade Deal Rise
DJ
01/08SANOFI : and Regeneron Restructure Immuno-Oncology Collaboration for Discovery a..
AQ
01/08SANOFI : revises immuno-oncology deal with Regeneron
AQ
More news
Financials (€)
Sales 2018 34 950 M
EBIT 2018 8 419 M
Net income 2018 5 008 M
Debt 2018 16 786 M
Yield 2018 4,22%
P/E ratio 2018 17,21
P/E ratio 2019 16,17
EV / Sales 2018 3,08x
EV / Sales 2019 2,96x
Capitalization 90 935 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 82,4 €
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-1.94%104 344
JOHNSON & JOHNSON0.24%344 044
PFIZER-2.93%245 746
ROCHE HOLDING LTD.4.13%221 817
NOVARTIS1.59%221 313
MERCK AND COMPANY-2.50%190 790